By Joe Hoppe

 

Omega Diagnostics Group PLC said Tuesday that technology partner Mologic Ltd. has requested an independent evaluation of its coronavirus test, but that this won't have implications for its U.K. government manufacturing contract.

The London-listed medical-diagnostics company said Mologic, its partner in developing a rapid coronavirus test, has requested research lab Porton Down evaluate its test with an independent party observing. The move comes in response to media speculation that Mologic's tests have been blocked by the U.K. government.

The company said this won't affect its contract with the Department of Health and Social Care, or DHSC. Under that contract it will use equipment loaned by the U.K. government to manufacture whichever test the DHSC approves.

Shares at 1039 GMT were down 4.5 pence, or 6.5%, at 65.0 pence. Shares fell as much as 14% earlier in the session.

 

Write to Joe Hoppe at joseph.hoppe@wsj.com

 

(END) Dow Jones Newswires

June 15, 2021 06:59 ET (10:59 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Omega Diagnostics Charts.